Acne

Using triple-combination clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel over layered topicals improved application evenness, according to a study.

Fixed-dose triple combination CAB gel showed efficacy in treating acne in both male and female patients aged 9 years and older, according to pooled data from two studies.

Clindamycin remains clinically relevant and safe in the treatment of acne vulgaris, according to a comprehensive published review.

Nonablative laser therapy plus topical antioxidants significantly decreased post-inflammatory dyschromia associated with acne vulgaris, especially in patients with skin of color, according to a study.

A study on cancer-causing benzene in acne products was Healio Dermatology’s most-read article of October, with coverage from clinical meetings also garnering attention.

New data showed Winlevi reduced oil production, remained stable when used in conjunction with other topical acne medications and improved outcomes in skin of color, Sun Pharma announced in a press release.

ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.

A new study confirmed previous findings that acne products containing benzoyl peroxide have high levels of cancer-causing benzene which are not stabilized by encapsulation techniques even at room temperature.

Researchers identify two key genes that contribute to the pathogenesis of acne, potentially opening doors for new treatment approaches, according to a study.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.